Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 1472 of 2842 -
Monday, February 09 2026 | 02:34:35 AM

Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM

Toronto, Ontario–(Newsfile Corp. – May 9, 2025) – Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) (“Neural” or the “Company”), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has submitted a renewal application to Servicio Nacional …

Read More »

Kiora Pharmaceuticals Reports First Quarter Results; Initiating Two Phase 2 Trials for Treatment of Retinal Diseases; Cash and Short-term Investments Expected to Fund Operations into Late 2027

Encinitas, California–(Newsfile Corp. – May 9, 2025) – Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) today announced first quarter 2025 financial results and provided an update on its pipeline of therapeutics for the treatment of retinal diseases. Key first quarter and 2025 year-to-date corporate highlights include: Received approval …

Read More »

Standard Uranium Announces Signing of Definitive Agreement to Option Corvo Project in Eastern Athabasca Basin

Vancouver, British Columbia–(Newsfile Corp. – May 9, 2025) – Standard Uranium Ltd. (TSXV: STND) (OTCQB: STTDF) (FSE: 9SU0) (“Standard Uranium” or the “Company”) is pleased to announce that it has signed a definitive property option agreement (the “Option Agreement”), dated May 8, 2025, with Vital Battery Metals Inc. (CSE: VBAM) …

Read More »